Intellipharmaceutics International Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Intellipharmaceutics International Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2023.
  • Intellipharmaceutics International Inc. Operating Lease, Right-of-Use Asset for the quarter ending August 31, 2023 was $37.8K, a 11.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $37.8K -$4.72K -11.1% Aug 31, 2023 6-K 2023-10-16
Q2 2023 $75.2K -$6.94K -8.45% May 31, 2023 6-K 2023-09-26
Q1 2023 $113K -$9.97K -8.12% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $151K +$151K Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $42.5K +$4.33K +11.3% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $82.1K +$8.91K +12.2% May 31, 2022 6-K 2022-07-21
Q1 2022 $123K +$20K +19.5% Feb 28, 2022 6-K 2022-04-14
Q4 2021 $0 -$138K -100% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $38.2K Aug 31, 2021 6-K 2021-10-15
Q2 2021 $73.2K May 31, 2021 6-K 2021-07-15
Q1 2021 $103K Feb 28, 2021 6-K 2021-04-14
Q4 2020 $138K +$138K Nov 30, 2020 20-F/A 2022-05-09
Q4 2019 $0 Nov 30, 2019 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.